Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Pfaff

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Scientific Reports|March 18, 2017
A Biologically-validated HCV E1E2 Heterodimer Structural ModelMatteo Castelli, Nicola Clementi, Jennifer Pfaff, et al.
Drug Discovery Today|August 31, 2014
HCV E2 core structures and mAbs: something is still missingMatteo Castelli, Nicola Clementi, Giuseppe A Sautto, et al.
AIDS Research and Human Retroviruses|January 9, 2010
HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entryJohn C Tilton, Heather Amrine-Madsen, John L Miamidian, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Scientific Reports|March 18, 2017
A Biologically-validated HCV E1E2 Heterodimer Structural ModelMatteo Castelli, Nicola Clementi, Jennifer Pfaff, et al.
Drug Discovery Today|August 31, 2014
HCV E2 core structures and mAbs: something is still missingMatteo Castelli, Nicola Clementi, Giuseppe A Sautto, et al.
AIDS Research and Human Retroviruses|January 9, 2010
HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entryJohn C Tilton, Heather Amrine-Madsen, John L Miamidian, et al.
Pageof 1